These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 502356)

  • 1. [Combined infusion of nitroprusside and dobutamine in the treatment of severe congestive heart failure (author's transl)].
    Cyran J; Bolte HD
    Klin Wochenschr; 1979 Sep; 57(17):883-91. PubMed ID: 502356
    [No Abstract]   [Full Text] [Related]  

  • 2. Calculations for dopamine, dobutamine and nitroprusside dosages.
    Nappi JM
    Am J Hosp Pharm; 1979 Jul; 36(7):881, 887. PubMed ID: 474577
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic equivalence of automated nitroglycerin- and nitroprusside-infusions combined with dobutamine for augmentation of cardiac output in patients following aorta coronary bypass-operation.
    Pomer S; Sarai K; Krause E; Satter P
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):602-7. PubMed ID: 6437993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined medication of nitroprusside and dopamine or dobutamine in acute heart failure].
    Ye JM
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):252-4. PubMed ID: 6544205
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of a sodium nitroprusside-dobutamine combination in left cardiac failure].
    Moore N; Champoud O; Berland J; Cribier A; Letac B
    Therapie; 1985; 40(2):99-103. PubMed ID: 4002197
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery.
    Pomer S; Elert O; Sarai K; Satter P
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):77-81. PubMed ID: 3957495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure.
    Applefeld MM; Newman KA; Grove WR; Sutton FJ; Roffman DS; Reed WP; Linberg SE
    Am J Cardiol; 1983 Feb; 51(3):455-8. PubMed ID: 6823859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of sodium nitroprusside in congestive heart failure (author's transl)].
    Tao SC; Liu LS; Wang LL; Ge H; Yao KB
    Zhonghua Xin Xue Guan Bing Za Zhi; 1979; 7(3):178-82. PubMed ID: 553004
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
    Mikulic E; Cohn JN; Franciosa JA
    Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dobutamine in heart failure.
    Chatterjee K; Bendersky R; Parmley WW
    Eur Heart J; 1982 Dec; 3 Suppl D():107-14. PubMed ID: 6761125
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of sodium nitroprusside and dobutamine on the ventricular myocardium in patients with severe left cardiac insufficiency].
    Cyran J; Bolte HD
    Verh Dtsch Ges Inn Med; 1978; (84):683-6. PubMed ID: 742099
    [No Abstract]   [Full Text] [Related]  

  • 12. Outpatient dobutamine infusion using a totally implantable infusion pump for refractory congestive heart failure.
    Berger M; McSherry CK
    Chest; 1985 Aug; 88(2):295-6. PubMed ID: 4017685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Optimal" left ventricular filling pressure during nitroprusside infusion for congestive heart failure.
    Franciosa JA; Dunkman WB; Wilen M; Silverstein SR
    Am J Med; 1983 Mar; 74(3):457-64. PubMed ID: 6829591
    [No Abstract]   [Full Text] [Related]  

  • 14. [Simplified preparation of sodium nitroprusside for intravenous use (author's transl)].
    Zheng WX
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Sep; 8(3):238-9. PubMed ID: 7307957
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced conditioning in congestive heart failure.
    Leier CV; Huss P; Lewis RP; Unverferth DV
    Circulation; 1982 Jun; 65(7):1382-7. PubMed ID: 7074796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Present-day views on the therapeutic use of nitroprusside].
    Matusewicz W
    Pol Arch Med Wewn; 1981 Jan; 65(1):65-71. PubMed ID: 7291031
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.
    Capomolla S; Febo O; Opasich C; Guazzotti G; Caporotondi A; La Rovere MT; Gnemmi M; Mortara A; Vona M; Pinna GD; Maestri R; Cobelli F
    Eur J Heart Fail; 2001 Oct; 3(5):601-10. PubMed ID: 11595609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of oral ephedrine given alone or combined with nitroprusside infusion in patients with severe left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Cardiol; 1979 Jan; 43(1):79-85. PubMed ID: 758774
    [No Abstract]   [Full Text] [Related]  

  • 20. Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure.
    Roffman DS; Applefeld MM; Grove WR; Talesnick BS; Sutton FJ; Newman KA; Reed WP
    Clin Pharm; 1985; 4(2):195-9. PubMed ID: 3987220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.